Non-canonical NF-κB signaling pathway

被引:900
|
作者
Sun, Shao-Cong [1 ]
机构
[1] Univ Texas Grad Sch Biomed Sci Houston, Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
关键词
NF-kappa B; non-canonical NF-kappa B; alternative NF-kappa B; p100; NIK; IKK; TRAF; LYMPHOTOXIN-BETA-RECEPTOR; TRCP UBIQUITIN LIGASE; ALPHA-DEPENDENT APOPTOSIS; T-CELL LEUKEMIA; NF-KAPPA-B2; P100; IKK-ALPHA; HELICOBACTER-PYLORI; MULTIPLE-MYELOMA; TRANSCRIPTIONAL ACTIVITY; LYMPHOCYTE-ACTIVATION;
D O I
10.1038/cr.2010.177
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The non-canonical NF-kappa B pathway is an important arm of NF-kappa B signaling that predominantly targets activation of the p52/RelB NF-kappa B complex. This pathway depends on the inducible processing of p100, a molecule functioning as both the precursor of p52 and a RelB-specific inhibitor. A central signaling component of the non-canonical pathway is NF-kappa B-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, I kappa B kinase-kappa (IKK alpha), for triggering p100 phosphorylation and processing. A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-kappa B signaling involves NIK stabilization. Tight control of the fate of NIK is important, since deregulated NIK accumulation is associated with lymphoid malignancies.
引用
收藏
页码:71 / 85
页数:15
相关论文
共 50 条
  • [41] Restricting non-canonical NFκB
    Andrea Du Toit
    Nature Reviews Molecular Cell Biology, 2014, 15 (3) : 151 - 151
  • [42] Role for protein kinase Cθ (PKCθ) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-κB activation
    Li, YQ
    Sedwick, CE
    Hu, JR
    Altman, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) : 1217 - 1223
  • [43] Delineation of canonical and non-canonical NF-κB pathways in multiple myeloma:: Therapeutic implications
    Hideshima, Tern
    Raje, Noopur
    Carrasco, Ruben
    Ikeda, Hiroshi
    Okawa, Yutaka
    Kiziltepe, Tanyel
    Valet, Sonia
    Pozzi, Samantha
    Chauhan, Dhanninder
    Mitsiades, Constantine
    Podar, Klaus
    Tai, Yu-Tzu
    Munshi, Nikhil C.
    Richardson, Paul G.
    Anderson, Kenneth C.
    BLOOD, 2007, 110 (11) : 206A - 206A
  • [44] Constitutive non-canonical NFκB signaling in pancreatic cancer cells
    Wharry, Catherine E.
    Haines, Kathleen M.
    Carroll, Richard G.
    May, Michael J.
    CANCER BIOLOGY & THERAPY, 2009, 8 (16) : 1567 - 1576
  • [45] Non-canonical pathway network modelling and ubiquitination site prediction through homology modelling of NF-κB
    Ghosh, Sayantan
    Dass, J. Febin Prabhu
    GENE, 2016, 581 (01) : 48 - 56
  • [46] Disseminated tuberculosis is associated with impaired T cell immunity mediated by non-canonical NF-κB pathway
    Jiang, Jing
    Cao, Zhihong
    Li, Binyu
    Ma, Xihui
    Deng, Xianping
    Yang, Bingfen
    Liu, Yanhua
    Zhai, Fei
    Cheng, Xiaoxing
    JOURNAL OF INFECTION, 2024, 89 (03)
  • [47] Non-canonical NF-κB signaling in endothelial cells may enhance synovial inflammation by stimulating angiogenesis
    Ae-Ri Noort
    Katinka PM van Zoest
    Paul Peter Tak
    Sander W Tas
    Journal of Translational Medicine, 9 (Suppl 2)
  • [48] Activation of non-canonical NF-κB pathway mediated by STP-A11, an oncoprotein of Herpesvirus saimiri
    Cho, Il-Rae
    Jeong, Sunam
    Jhun, Byung Hak
    An, Won G.
    Lee, BokSoo
    Kwak, Youm-Tae
    Lee, Sun-Hwa
    Jung, Jae U.
    Chung, Young-Hwa
    VIROLOGY, 2007, 359 (01) : 37 - 45
  • [49] THE IMPACT OF ALTERNATIVE (NON-CANONICAL) NF-κB PATHWAY INHIBITION IN PREVENTING INTESTINAL BARRIER DYSFUNCTION IN IBD
    Tang, Joseph
    Papoutsopoulou, Stamatia
    Mackay, Simon
    Paul, Andrew
    Duckworth, Carrie
    Pritchard, Mark
    GUT, 2022, 71 : A140 - A140
  • [50] Manipulation of Non-canonical NF-B Signaling by Non-oncogenic Viruses
    Struzik, Justyna
    Szulc-Dabrowska, Lidia
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (01) : 41 - 48